38 Scopus citations


Post-mortem studies of neurological diseases are not ideal for identifying the underlying causes of disease initiation, as many diseases include a long period of disease progression prior to the onset of symptoms. Because fibroblasts from patients and healthy controls can be efficiently reprogrammed into human induced pluripotent stem cells (hiPSCs), and subsequently differentiated into neural progenitor cells (NPCs) and neurons for the study of these diseases, it is now possible to recapitulate the developmental events that occurred prior to symptom onset in patients. We present a method by which to efficiently differentiate hiPSCs into NPCs, which in addition to being capable of further differentiation into functional neurons, can also be robustly passaged, freeze-thawed or transitioned to grow as neurospheres, enabling rapid genetic screening to identify the molecular factors that impact cellular phenotypes including replication, migration, oxidative stress and/or apoptosis. Patient derived hiPSC NPCs are a unique platform, ideally suited for the empirical testing of the cellular or molecular consequences of manipulating gene expression.

Original languageEnglish
Article numbere52495
JournalJournal of Visualized Experiments
Issue number96
StatePublished - 21 Feb 2015


  • Induced pluripotent stem cells
  • Issue 96
  • Lentiviral transduction
  • Medicine
  • Neural differentiation
  • Neural progenitor cells
  • Neurosphere migration assay
  • Psychiatric disease


Dive into the research topics of 'A guide to generating and using hiPSC derived NPCs for the study of neurological diseases'. Together they form a unique fingerprint.

Cite this